The Association says it has produced the leaflet after seeing an increasing number of dogs diagnosed with clinical or subclinical infection, along with reports of its zoonotic impact.
The document outlines the most important considerations concerning B. canis including transmission, diagnosis, management, public health implications and legislative requirements.
It takes into consideration information available from relevant Government Departments.
BSAVA says the document is by no means exhaustive but is intended to provide useful information and signpost to further resources.
www.bsavalibrary.com/brucella_canis
Photo: Walker16/Wikipedia. CC BY-SA 4.0.
Vets Now Referrals has launched a new specialist veterinary referral service to serve Aberdeen and the North.
Richard Coe MA VetMB CertSAS DipECVS MRCVS (pictured right) and Professor Stuart Carmichael BVMS MVM DSAO MRCVS will attend Ardene House Veterinary Hospital in Aberdeen on a monthly rotational basis to offer specialist care to pets from the area. Richard is a European Specialist in Small Animal Surgery and Professor Carmichael is an internationally recognised expert in veterinary orthopaedics.
By bringing these two specialist surgeons to Aberdeen, it will mean that vets can refer their clients to have their initial consultations and diagnoses locally by either Richard or Stuart, reducing the need for a lengthy journey to Vets Now Referrals in Glasgow where they are usually based. Vets Now says that where possible, treatment plans will be carried out in Aberdeen, however complex treatments may require the facilities and high tech equipment at its Glasgow Hospital.
Any vet wishing to make an enquiry about referring to Richard or Stuart should call 01224 478 041. Further information about the service can also be found on www.vetsnowreferrals.com/aberdeen.
Tricia Colville, Hospital Manager of Vets Now Referrals, Glasgow, said: "We are delighted to now be able to offer our specialist service for vets in the North of Scotland to utilise for their clients. The Vets Now Referrals Hospital in Glasgow has been so successful since it opened over a year ago, benefiting hundreds of pets and their owners. Bringing the service to Aberdeen and the surrounding region will provide vets with local access to Richard Coe and Professor Stuart Carmichael who are both renowned in their fields and for their clients this provides a convenient option which will greatly reduce time-consuming, distressing and costly journeys for them."
Pfizer has repeated it's call for veterinary practice staff to take part in its Vet Support+ independent, industry-wide survey of employee engagement.
The survey gives practice team members, who are not partners or owners, the chance to have their say about their role and career and the future of the profession. Participants are asked to consider how they feel towards their practice and delve into issues on teamwork and communication, management techniques, personal development opportunities and working environment.
More than 3,000 vet practice staff have already completed the survey, a phenomenal early response which suggests practice employees are keen to have their voices heard. However, the closing date for the survey isn't till Friday 29th July, so if you haven't yet had a chance to do the survey, there is still time.
Pfizer Business Consultant, Vanessa Wilson, has more than 20 years experience helping businesses, teams and individuals achieve their goals. She is not surprised at the significant early response: "Questions on the level of employee engagement and satisfaction come up all the time in the work we do with practices. I'm not surprised that staff are using this opportunity to have their voice heard.
"Once completed, this survey will provide some very useful data and direction for the industry as a whole and I'd like to think it will identify opportunities for both individual career development and practice growth."
All members of staff employed within a practice who have not received a mailing and wish to participate are welcome to respond online. http://www.noesis-mi.com/surveys/employeesurvey/.
Pfizer says the findings, which are expected to be released in the autumn, will deliver a national and regional view of the current employee engagement landscape.
For further information about Vet Support+ Business Services from Pfizer visit www.vetsupportplus.co.uk.
Bayer Animal Health has announced the launch of, Dinalgen (ketoprofen), an NSAID injection approved for use in cattle, pigs and horses.
Dinalgen is available as a 150mg/ml Solution for Injection, and Bayer says the more concentrated format allows the product to provide the smallest dose, fast relief NSAID currently available for cattle in the UK.
In cattle, Dinalgen is licensed for the reduction of inflammation and pain associated with lameness, post-partum, and musculoskeletal disorders; the reduction of fever associated with bovine respiratory disease; and the reduction of inflammation, fever and pain in acute clinical mastitis in combination with antimicrobial therapy where appropriate. The withdrawal period for milk is zero hours and for meat two days.
In pigs, Dinalgen is licensed for the reduction of pyrexia in cases of respiratory disease and postpartum dysgalactia syndrome in sows, in combination with antimicrobial therapy.
In horses, Dinalgen is licensed for the reduction of inflammation and pain associated with osteoarticular and musculoskeletal disorders, including lameness, laminitis, osteoarthritis, synovitis, and tendinitis. It also aids the reduction of visceral pain associated with colic.
Sharon Cooksey, MRCVS, FAP group product manager at Bayer, said: “We are excited to have this new addition to our portfolio. It is a good fit with our existing products.
"A recent field study*, carried out by Nottingham university, has shown that NSAID (ketoprofen) treatment maximises the chance of recovery from lameness in dairy cattle. Lameness remains one of the “big three” issues in dairy practice so maybe it is time we moved on from hoof blocks and/ or trimming in isolation and onto a more multi-layer approach. We have some great support tools in the pipeline to help both vets and farmers recognise and manage animals at risk for lameness.”
For further product information visit www.noahcompendium.co.uk or contact your local Bayer territory manager.
The change to the Practice Standards rules means that RVNs who have at least five years’ experience within the profession are eligible to apply to become PSS Assessors.
PSS Assessors are employees of the RCVS who are responsible for visiting practices that want to join the scheme, are undergoing their re-accreditation assessment or have applied for one or more of the PSS Awards, to ensure they meet the criteria.
The decision to allow RVNs to become PSS Assessors had already been approved by both the Practice Standards Group (the steering committee for the Scheme comprising representatives from all of the major veterinary and veterinary nursing organisations in the UK) and the RCVS Standards Committee.
Matthew Rendle is the Chair of VN Council and also sits as a member of RCVS Council. He said: “I am delighted to see that there is now a pathway to recruit veterinary nurses as PSS Assessors and hope that many of my VN colleagues will take up this opportunity to apply to join the excellent team responsible for ensuring that the Scheme’s stringent standards are met.
"We know that, on a practice-by-practice basis, veterinary nurses often play a big role in helping to coordinate and ensure that the requirements of the Practice Standards Scheme are met, for example, by preparing their team for the assessment, liaising with the RCVS and the Assessor and making sure all standards are complied with in advance. It is great to see that the crucial role they often play in meeting standards is reflected in opening up the ability to become PSS Assessors."
Mandisa Greene, RCVS President and Chair of the Practice Standards Group, added: “This is such an important development for the veterinary nursing profession whose role in the Practice Standards Scheme has long been recognised as invaluable. This decision also opens up new career advancement opportunities for the profession as well, which I’m sure is very welcome."
When the next recruitment round for PSS Assessors takes place, RVNs will be invited to apply to join the roster of Assessors.
In addition to approving the role of RVNs as PSS Assessors, Council also approved a new Equine Emergency Services Clinic accreditation to help incorporate the emerging business model of veterinary practices that provide ambulatory emergency services for equids.
The new accreditation would require these practices to meet the applicable PSS Core Standards, plus the requirements contained in an additional Equine Emergency Services module. The full details of the requirements will be published in due course.
For more information about the Practice Standards Scheme visit: www.rcvs.org.uk/pss
Purina says the foods contain adjusted and graded levels of protein and phosphorus to address the delicate balance of providing needed protein in older cats against uraemic toxin production in late phase renal decline.
The current advice is that phosphate should be restricted when the renal patient has confirmed CKD, and IRIS provides therapeutic serum phosphate targets for each stage.
Dr Ellie Groves BA(Hons) VetMB MRCVS, Purina Technical Manager for the UK and Ireland, said: “As obligate carnivores, cats have a high requirement for protein, however, around 20% of senior cats have decreased ability to digest protein, and so are absorbing less protein.
"An inadequate intake of protein leads to loss of lean body mass as muscle is catabolised to meet this need.
"We know that this loss of lean body mass is significantly correlated with an increased risk of mortality.
"But we need to be careful – in renal disease, there is the potential for protein breakdown products to increase in the circulation, acting as toxins.
"So, we need to fine-tune the amount of protein, depending on the stage of chronic renal insufficiency (CRI).
"A dual approach, with Early and Advanced products, allows tailoring of protein levels.”
“Alongside protein, phosphorus content is also tailored to the stage of kidney decline.
"Restricting phosphorus can slow the progression of chronic kidney disease by reducing morphological damage to the kidneys and is thought to be the most important influencer of survival in cats with CKD.
"The levels of phosphorus in the products, are tailored, alongside the protein, to reflect the needs of the cat, with increased restriction when cats are in advanced decline and the kidneys are struggling most.”
NF Renal Function Early Care is available in a dry format (1.5kg) and a pouch (tender pieces with chicken 85g).
NF Renal Function Advanced Care is available in 1.5kg and 5kg packs of dry food, and ‘wet’ options of tender pieces with chicken/ salmon (85g pouches) and a mousse (195g can).
Both diets are now available in veterinary wholesalers.
Preliminary results, which recorded a decline in the quantities of antimicrobials prescribed from 2014 to 2018, were published in 2022.
A further audit has now been undertaken in all 22 of the company's first opinion practices to investigate the age, breed and estimated weight of each horse, the clinical indication for antibiotic use, the drugs prescribed, their dose rates, the route of administration and whether culture and sensitivity were used to guide antimicrobial selection.
Data collection was completed in August 2022.
This secondary audit was conducted using a ‘point prevalence’ survey, in which each CVS Equine first opinion Quality Improvement Lead gathered information about all systemic antibiotics prescribed by each of their practices on one day a month for 12 consecutive months.
The project yielded information on 331 cases where systemic antimicrobials were prescribed.
Complete data about the first line-drug selection were available for 261 prescriptions.
The commonest prescribed antimicrobial was sulfadiazine/trimethoprim (41%), followed by oxytetracycline (23%), procaine penicillin (16%), doxycycline (13%), gentamicin (4%), metronidazole (1%), ceftiofur (1%) and enrofloxacin (1%).
Highest priority critically important antimicrobials (ceftiofur and enrofloxacin) were only prescribed in four horses (clinical indications for these included possible sepsis, skin infection, lower respiratory tract infection and a wound complication – in none of these cases was the first-line drug selection based on the results of culture and sensitivity.
Overall, the clinical indications for antimicrobial use were recorded in 246 cases; the commonest indications were cellulitis/lymphangitis (27%), uncomplicated wounds (19%), surgical prophylaxis (15%), respiratory infections (11%) and skin infections (8%).
Hattie Lawrence, Director of CVS Equine, said: “Though the impact of this work is yet to be documented, there is anecdotal evidence that it has raised awareness amongst our veterinarians of the importance of antimicrobial stewardship.
"Taken together, the results of both pieces of work will be used to help develop and inform clinical audits and clinical guidelines of antimicrobial use in horses.”
Reference
Bayer Animal Health has announced that its parasiticide - Advocate Spot-On Solution - is now licensed to be used weekly, and for a prolonged period of time, in severe cases of demodicosis in dogs.
According to the company, recent work carried out to obtain the new weekly indication shows a number of benefits of this increased application frequency for severely affected animals. Dogs treated on a weekly basis showed a greater reduction in mite numbers, fewer clinical signs, and improved hair regrowth and weight gain over the trial period, when compared to dogs treated monthly.
Advocate remains licensed for monthly use on mild to moderate presentations.
A spokesperson for the company said: "The new claim for the weekly use of Advocate should give veterinary surgeons a more effective route to go down when dealing with more severe cases, compared to monthly use. However, demodicosis is a complex condition which presents the practitioner with many challenges. So, from past experience with this condition, we would urge vets to be patient and also recognise the importance of treating any underlying disease process likely to exacerbate the situation."
Advocate Spot-on Solution has also been recently licensed for the prevention of Angiostrongylus vasorum, and the treatment of Crenosoma vulpis.
For further information, please contact your Bayer representative or the Bayer technical advice line on 0845 1305995.
The gallery was traditionally held in-person at the NAVC’s annual Veterinary Expo & Meeting (VMX) in Florida.
Now, for the first time since it began in 2012, the gallery is accessible to everyone everywhere months before the live event in June.
The new Virtual VMX New Product Gallery went live this week and will run until 3rd September 2021. It showcases 21 new product innovations from the following companies: BioNote; Boehringer Ingelheim Animal Health; Dechra Veterinary Products; Epicur Pharma; GVL; Hill’s Pet Nutrition, Inc.; Merck Animal Health; Neogen Corporation; Ogena Solutions; Purina; Royal Canin; Vetoquinol; Zoetis Petcare.
NAVC CEO Gene O’Neill said: "Each year, NAVC’s panel of experts select the most innovative new products and services to be showcased as part of the VMX Expo. We are excited to take this VMX staple and, for the first time, make it universally available to members of our global veterinary community everywhere.
"And they don’t have to wait until June to learn about and try these important new products. The VMX Virtual New Product Gallery launch is part of the NAVC’s expanding virtual portfolio which breaks down barriers of geography and time to make the best products the veterinary industry has to offer available to veterinary professionals worldwide.” The gallery is free to access. You can register here: https://vmxvirtual.simexpo.com/page/100
The ophthalmology service, which offers cataract surgery, corrective eyelid surgery and corneal disease management amongst other things, is headed by RCVS and US Ophthalmology Specialist, James Histed (pictured right)
The hospital, which has doubled in size to 30,000ft², now has a purpose-built theatre complex, a new reception and waiting area, 12 additional consulting rooms and a new rehabilitation centre equipped with a water treadmill and a large arena for treatment and gait analysis.
It also has a new lecture theatre where SCVS can deliver its CPD programme and parent company IVC can deliver its intern and residency programme.
The company says that its redevelopment has focused on employee wellbeing, to which end there is a new staff area for the 200-strong team a place to gather, dine and relax.
Kennel space for staff dogs has also been increased to support SCVS’s ‘bring your dog to work’ policy.
The new hospital facility is fully operational and open 24/7 for referrals, supporting colleagues from surrounding vet practices.
www.scvetspecialists.co.uk
George won the Best Medicine Award for: 'Predictors of clinically significant bleeding in dogs with severe thrombocytopenia'.
Kathryn won the Best Practitioner Award for: 'Reflecting on first opinion clinical improvement project across 39 UK vet practices to support diagnosis and management of OA.'
Sebastian won the Best Surgery Award for: 'Complications and outcomes following surgical management of Achilles Tendon injury'
The Best Student Award was won by Michelle Demkova for: 'Lifting the flap on otitis externa in dogs under primary veterinary care in the UK – the VetCompass view'.
In addition, Clare Jones RVN won the Best Poster Award for: 'Confidence with CPR within Veterinary Professionals. Would standardised CPR training help confidence within Veterinary Professionals?'
Submissions for the 2025 Clinical Abstracts will open on 9th September 2024, and will close on 18th October, and those chosen will present their work at BSAVA Congress 2025, in Manchester on 20th – 22nd March.
https://www.bsavacongress.com/register-interest
Generally, veterinary practices may remain open, but there are national variations in what services should be offered and how, including the conditions under which remote prescribing can be used to help support a case.
Wales currently has the tightest ‘firebreak’ restrictions, meaning practices can only provide essential and urgent work until midnight on 8 November 2020, thereafter, returning to usual operations in line with Wales’ standard measures around workplace safety.
England and Northern Ireland are under national restrictions (4 Nov – 2 Dec, and 16 Oct – 12 Nov, respectively), meaning practices can provide treatment essential for maintaining animal health and welfare, along with non-urgent work providing that social distancing measures and safe working can be maintained.
Veterinary surgeons practising in these three countries may also choose to support a case remotely at an earlier stage, for example, through the remote prescribing of POM-Vs without first having conducted a physical examination.
Scotland remains the only country under regional tiered restrictions, meaning practices can continue to provide treatment whilst maintaining social distancing; however, before remote prescribing is offered, veterinary surgeons should first consider whether the animal can be brought under their care.
The full guidance and corresponding flowcharts should be consulted together and are available at www.rcvs.org.uk/covidfaq2and www.rcvs.org.uk/covidfaq4.
Fort Dodge has announced that a challenge study has demonstrated the ability of Duvaxyn® IE-T Plus equine influenza vaccine to cross protect against A/equi-2/Sydney/07 (H3N8) two weeks after a two dose primary course. This strain was responsible for the financially devastating equine influenza outbreak in Australia in August 2007.
Duvaxyn IE-T Plus is an inactivated whole virus equine influenza vaccine, adjuvanted with an aqueous-based adjuvant. According to Fort Dodge, experts at a recent WHO meeting on human vaccines expressed the view that whole virus vaccines have the potential to induce a stronger and more broadly based response to circulating influenza strains than those contained in sub-unit vaccines because of the presence of the full set of virus proteins in the vaccine*.
The study, conducted by the Animal Health Trust, involved two groups of EIV seronegative horses. The first group, consisting of seven vaccinates, were given two dose of Duvaxyn IE-T Plus, 28 days apart, and challenged with A/equi-2/Sydney/07 (H3N8) virus strain 14 days after the second vaccination. The second group of unvaccinated horses was challenged at the same time. Duvaxyn IE-T Plus caused a statistically significant reduction in both clinical signs of the disease and in viral shedding.
Helen Barnes, EMEA Equine Business Manager for Fort Dodge, said: "The results of this challenge study provide reassurance for owners that horses vaccinated with Duvaxyn will be protected against circulating strains of equine influenza, including the Sydney strain which proved so damaging.
"As the benefits offered by whole virus technology are increasingly recognised, the popularity of vaccines based on this technology is re-emerging, particularly to combat a potential pandemic.
"The entire Duvaxyn range of equine vaccines, including the recently licensed Duvaxyn WNV for West Nile Virus, are based on the whole virus approach as we believe it offers a broad and consistent level of protection."
Petplan has announced the finalists for the 2012 Petplan Veterinary Awards.
According to the company, the awards have been more popular than ever, with over 3,000 nominations submitted for exceptional veterinary staff across the UK.
The finalists for each of the categories are:
Vet of the YearZaila Dunbar, Queens Park Veterinary Practice - London Tony Barnes, Manor Veterinary Clinic - FolkestoneMark Taylor, Feldon Veterinary Centre - Bedworth
Vet Nurse of the YearLucy Kells, The Wildlife Aid Foundation - LeatherheadRachael Harris, Elms Veterinary Surgery - MonmouthSarah Algar, Brentknoll Veterinary Centre Ltd - Worcester
Support Staff of the YearSarah Bowler, Holly House Veterinary Surgery - KnutsfordJane Wyatt, George Hunt and Son - PoyntonCathy Campbell, Haygate Veterinary Centre - Telford
Vet Practice of the YearEastcott Veterinary Clinic and Hospital - SwindonPrince Bishop Veterinary Hospital - County DurhamBroadleys Veterinary Hospital - Stirling
Simon Masding, Petplan's Head of Sales and Partnerships, said: "The Vet of the Year Awards are the highlight of our Petplan calendar because they recognise the dedication that the veterinary industry puts into providing the nation's pets with the best possible treatment. Each year the nominations reach an even higher standard and we're delighted with this year's finalists. At Petplan we work with more veterinary professionals than any other insurance provider and it is through these awards that we thank the profession on behalf of UK pet owners."
Petplan has also announced that comedian Seann Walsh, known for his appearances on shows like Mock the Week and Michael McIntyre's Comedy Roadshow, will be this year's compère for the Vet of the Year Awards. Following in the footsteps of previous compères Michael McIntyre, Alistair McGowan, Frankie Boyle and Jason Manford; he will be entertaining this year's guests on the 12th April at Birmingham Town Hall.
For further information visit www.petplan.co.uk/vetawards/
Kruuse UK has announced the launch of its new Mud Fever Kits for horses.
Kruuse says the launch follows independent studies last year by Aimi Duff BVM&S, MRCVS (Scott, Mitchell & Associates, Hexham) on the use of Manuka ND dressings for the treatment of Mud Fever.
The kit contains one complete treatment for two legs (or two complete treatments for one leg) including all dressings. There is also a step-by-step guide from the "Ask the Vet" series which explains best treatment protocol, designed to help veterinary surgeons dispense the kit directly to clients with confidence.
According to the company, the benefits of using medical grade Manuka Honey in the treatment of Mud Fever include:
Andrew Groom, Managing Director of Kruuse UK Ltd said: "We are delighted with the initial response to our unique Mud Fever Kits; such additions to our range continue to enhance the Kruuse commitment to equine wound care."
The British Safety Council has launched a new qualification to help people who drive as part of their work stay safe on the roads.
According to the organisation, the Level 2 Award in Safe Driving at Work provides work drivers with key knowledge of the hazards and risks associated with driving and equips them with valuable guidance on the measures available for reducing these risks, such as vehicle inspection, behaviour and defensive driving.
According to estimates from the Health and Safety Executive (HSE), up to a third of all road traffic accidents in Britain involve someone involved in work-related activity. In 2013, according to government figures, 1,713 people died on the road, with the total number of casualties standing at 183,670.
The Ofqual-regulated qualification, which is designed to be delivered by employers or training organisations, instructs learners on a range of topics including the particular risks associated with vulnerable road users, such as cyclists and pedestrians, the importance of regular vehicle safety checks and how to adapt driving style in response to changes in driving conditions or the actions of others.
Alex Botha, the British Safety Council's Chief Executive, said: "Driving can be a risky activity, a fact borne out by the high number of injuries and fatalities that occur annually on our roads.
"However, simple steps can be taken by employers and drivers to manage and reduce this risk. Our new Level 2 Award in Safe Driving at Work provides learners with all the essential knowledge to help them stay safe on the roads.
"Learners can expect to leave the qualification with a thorough knowledge of the main risks posed by driving - whether to themselves or other road users - and how to reduce them.
"Once registered with us, employers or training centres deliver the training using the high-quality teaching and student materials provided. Qualifications are assessed through a 45-minute multiple-choice examination that can be either taken online or on paper.
"This is a stand-alone qualification designed for delivery as a short course. It is also well-suited for integration into wider vocational programmes of study or, for example, as part of an induction programme. Students need no former knowledge or experience, so can come from a diverse range of educational and employment backgrounds.
"Safer driving habits should also feed through into workers' personal lives, providing employers with a valuable corporate social responsibility tool to help make our roads safer in and out of work."
The researchers say that previous research suggests that approximately 10% of diabetic cats are euthanised at the time of diagnosis, making it a significant cat welfare issue.
However, this figure was largely based on questionnaire-based research from several global locations.
This new study followed the survival of 1,053 cats with confirmed diabetes mellitus under UK primary-care practices in 2019, providing the most up-to-date baseline data on early death among diabetic cats in the UK, as well as examining risk factors for the development of diabetes among UK pet cats.
The study found:
Based on these findings, the researchers encourage veterinarians to more actively discuss diabetes mellitus risk with cat owners, particularly those with Burmilla and Burmese breeds, in the hope that raising awareness of the disease might improve outcomes through earlier diagnosis, and by taking actions that might prevent diabetes mellitus development in the first instance, such as preventing cats becoming obese.
Dr Oliver Waite, Senior Lecturer in Small Animal Medicine at Murdoch University, and primary author of the paper, said: “We hope that this new, large scale epidemiological study, investigating the second most common endocrine disease in cats, will help to highlight current as well as future areas to improve cat welfare.
"This is an exciting time for the management of diabetic cats but more work is still needed!”
Dr Dan O’Neill, Associate Professor in Companion Animal Epidemiology at the RVC, and co-author of the paper, said: “This new VetCompass study shows the value of everyone working in primary care practice sharing their anonymised clinical data to get a better understanding of real-world animal health.
"Awareness of the scale of the diabetes mellitus issue revealed here can empower veterinary professionals to engage in more conversations with owners about diabetes mellitus prevention in predisposed cats.”
Researchers and practitioners working in any field of academia, industry and/or clinical practice are invited to apply for an award of up to £2,000 to fund a research project relevant to the aims of the VMG, which represents veterinary professionals working in leadership and management roles.
The VMG says it has launched the scheme to help veterinary leaders embrace the challenges and opportunities faced by the sector and to help them to continue to meet patient needs effectively while remaining profitable.
VMG Junior Vice President Mr Richard Casey said: "Business landscapes are changing and the veterinary world is no exception. The VMG is ideally placed not only to support our members but also to help the wider profession. We hope that our grant scheme will support research that enhances our understanding of contemporary veterinary business, leadership and management and helps us to develop a solid evidence base for best practice. We are looking forward to receiving some exciting proposals."
Further information, including the Stage 1 application form and guidance notes, are available here: https://www.vetmg.com/vmg-research-awards/
The deadline for applications is 19 July 2019.
The RSPCA has published the results of a survey which found that teachers in the UK are strongly in support of teaching animal welfare in the classroom, with 93% of respondents stating they would teach animal welfare in the classroom if they had the time.
95% also said that they believe that teaching children about animal welfare would help make them more compassionate and socially aware.
According to the survey of almost 800 teachers across England and Wales, 83% felt animal welfare should be part of the national curriculum. However, some had concerns about how it would be integrated into existing frameworks, and whether it would mean more demands on already overworked teachers.
RSPCA formal education manager Claire Morris said: "We felt it is easy to sit on the sidelines and state that animal welfare should be part of the curriculum, but it is far more practical and helpful to show that it can be done."
To address these concerns, the RSPCA says it created over 90 free lesson plans for teachers, which are linked to the English and Welsh Curricula. Many of the RSPCA's lesson plans overlap in subject areas including Science, Citizenship, Literacy and Numeracy, as well as provide springboards for assemblies and student councils.
Claire added: "We urge the government to consider integrating animal welfare into our children's education as a matter of urgency - as skills such as empathy, compassion and social consciousness have value as a child goes through the education system as well as when they enter adulthood and the world of work."
The RSPCA says this is particularly important because only 70% of respondents knew what the five animal welfare needs - which are central to the Animal Welfare Act - are.
As well as looking at the ethical side of animal welfare, 92% of teachers also expressed a strong preference for lessons specifically on animals' role in food and clothing production. It was felt that with young people better connected than ever before, they have an increasing awareness of social issues and expect higher ethical standards from companies.
The Vet Wellbeing Awards, which are now in their fourth year, are designed to highlight positivity within the profession by sharing stories and initiatives from veterinary workplaces that demonstrate commitment to improving staff wellbeing.
The Awards also aim to support all practices to take a structured approach towards evaluating their own wellbeing support systems.
This year, for the first time, feedback will be given to practices that enter about the areas where they are doing well and those where they can improve. The organisers hope that this change to the Awards process will encourage practices to think of wellbeing support as an area of continuous development.
However, they also hope that practices will use the entry process as an opportunity to audit wellbeing even if they don't plan to enter.
Liz Barton, SPVS Board Member, said: "Going through the entry form and evaluation process is valuable for every vet practice, even if they don’t feel they’re ready to enter the Awards just yet. Sitting down as a practice team for a few hours and working through the questionnaire is a highly useful exercise for facilitating celebrating areas where your practice is doing well for wellbeing, and also highlighting some areas for improvement for years to come."
"We recommend all practices get into the habit of going through the process annually and choosing areas to focus and improve on, to build towards better wellbeing across all areas for all staff."
There are three award categories that practices can enter depending on the number of employees: small practice (15 or fewer full time equivalent team members (FTE)), medium practice (16 to 50 FTEs) or large practice (51 or FTEs).
The Award application form covers six aspects of work that, if well-managed, can promote wellbeing and reduce the risk of work-related stress, and the Award judges will be looking for evidence of commitment to enhancing wellbeing for each of these.
They are:
Promoting physical and psychological health at work
Relationships at work
Communication at work
Career development
Workload and work scheduling
Work demands
More examples of the type of evidence and initiatives that the Awards are looking for, together with the entry form, are available on the Vet Wellbeing Awards website: https://vetwellbeingawards.org.uk.
Winning and Highly Commended practices will receive a dedicated logo and certificate for display. The winners in each category will also receive two registrations and banquet tickets for SPVS/VMG Congress 2020.
In addition to the Wellbeing Awards, the RCVS and SPVS are also running the Practice Star nominations, which are open to all veterinary practices.
These nominations aim to support practices to thank someone in their team who has gone the extra mile to make the practice a happy place to work, whether this be through introducing an initiative that makes everyone’s work life better, going out of their way to support a colleague going through a tough time, or just making everyone smile.
To enter, practices need to send in their nominee’s name, job title and contact details, and a short paragraph explaining why they have been chosen. They will then receive a certificate congratulating them for being nominated as the practice’s very own ‘Practice Wellbeing Star’.
The closing date for both the Wellbeing Award entries and Practice Star nominations is Friday 22 November 2019.
Newmarket-based Test and Treat was one of three finalists, for its U-Treat test which enables vets to diagnose a UTI and get antibiotic sensitivity results in an hour.
Rachel Kirkby MRCVS, Business Development Director at Test and Treat, said: "It’s a great accolade to be recognised by such a prestigious award. The Vet Record Innovation Award celebrates new innovations that can bring about improvement and make a real difference to vets in practice – and that’s exactly what we’re aiming to do with U-Treat.”
The second finalist was the Animal Welfare Assessment Grid, developed by Public Health England (PHE), in collaboration with the University of Surrey School of Veterinary Medicine. Initially developed in zoos, rescue and research centres, there are plans now to develop it for use in small animal practice and in the farm sector.
The overall winner was PBD Biotech for Actiphage, its test for bTB and Johne's disease which gives very early detection, thereby allowing vets and farmers to prevent the spread of infection.
For more information, visit: https://bvajournals.onlinelibrary.wiley.com/doi/10.1002/vetr.267
Vet Sustain works to inspire and enable veterinary professionals to become leading forces in sustainability and improve the health and wellbeing of animals, people and the environment.
To that end, the company produces tools, training and communications for veterinary professionals centred around its six Veterinary Sustainability Goals (SDGs):
Gudrun Ravetz, Chair and Director of Vet Sustain, said: “We are very pleased to announce IVC Evidensia as a strategic partner of Vet Sustain.
"Veterinary professionals sit at the One Health triumvirate of people, planet and environment every day and working with IVC Evidensia will allow Vet Sustain to continue work on ambitious projects to support veterinary professionals to be active sustainability champions.”
You can find out more about IVC's Sustainability Report here: https://ivcevidensia.com/how-we-work/sustainability/
The aim of the survey is to provide a better understanding of the views, experiences and challenges faced by disabled and chronically ill people within the veterinary profession and provide an insight into how the profession and educational institutions can be more inclusive.
You do not have to be disabled or chronically ill to complete the survey, which will take you around 20 minutes to complete.
Claire Hodgson, director and co-founder of BVCIS, said: “Working in the veterinary professions with a chronic illness or disability can be hugely challenging, but there is currently a knowledge gap in terms of understanding exactly where the problems lie.
“A 2019 RCVS survey of the professions found that around 6.7% of vets and 7.4% of RVNs have a disability or medical condition that limits work that they can do, but the true figures are likely to be much higher.
"No reliable data for veterinary students currently exists.
“The purpose of this survey is to close that knowledge gap and help us understand how we can better support disabled and chronically ill people in the workplace and education to create a more inclusive working culture.\
“Those living with disability and chronic illness are often hugely resourceful and fantastic problem solvers because of the day-to-day challenges they have had to learn to overcome.
"They have a great deal to contribute to the sector, and it is important that they feel valued and respected and have access to the tools they need to thrive.
“Diversity makes the workforce stronger, so we are calling on as many different people as possible from across the veterinary community to complete our survey so that, together, we can help create a more inclusive workplace for all.”
The survey will be circulated by email to all RCVS registered veterinary surgeons in the near future.
Details will be circulated to students via their educational institutions.
The RCVS says all survey responses will be completely confidential, and results will only be analysed and reported at a level that does not allow identification of individuals in any way.
Completed surveys will not be seen by anyone at the RCVS or BVCIS – the IES will send through a report with key research findings to both the RCVS and BVCIS after the survey has closed.
Ceva Animal health has launched Marbox, a broad-spectrum anti-infective, based on marbofloxacin, for the rapid treatment of bovine mastitis and respiratory disorders. According to the company, Marbox effectively provides two products in one bottle because it can be used as a high dose single injection or administered at a lower dose over several days.
Ceva says mastitis and respiratory disorders currently account for around 60% of antimicrobial prescriptions. Marbox can be used intramuscularly as a single injection for the treatment of respiratory infection. Alternatively it can be used for the treatment of acute mastitis; intravenously for the first injection and then subcutaneously at a lower dose over three days. It has a milk withdrawal of just 36 hours after subcutaneous injection.
Marbox is presented in an ergonomic CLAS vial which makes for light and shock-resistant handling, resulting in fewer breakages and reduced costs. It is available in 100 and 250 vial sizes and contains 100mg marbofloxacin per ml.
Marbox can be used in combination with Meloxidyl, Ceva's new, single shot anti-inflammatory. The product joins Ceva's bovine range of anti-infectives, which includes Cevaxel, Florkem and Spectam Injectable.
For further product information contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at http://www.ceva.uk.com/
Zoetis has relaunched a broad spectrum intramammary treatment for clinical mastitis, as Lincocin Forte S.
For vets seeking to prescribe an alternative first-choice tube, independent mastitis authority Dr Andrew Bradley suggests it could be a logical, efficacious option, offering the combination of two active ingredients (lincomycin and neomycin) not available in other intramammary tubes.1
Zoetis points to studies which show that In combination, these have been found to have much higher efficacy than the sum of the two parts against Staphylococci aureus.2&3
The company says Lincocin Forte is effective against Gram positive and Gram negative pathogens, in particular staphylococcus, streptococcus and coliform bacteria.
In trials, the treatment produced clinical cure rates 21% higher than an ampicillin-cloxacillin comparison in undifferentiated mastitis cases. As first choice treatment for S uberis clinical mastitis, bacteriological cure rates were similar to a penicillin-streptomycin comparison.4 Against S aureus, aesculin-positive streptococci, and E coli, combined clinical-bacteriological cure rates were 175%, 32% and 21% higher respectively with Lincocin Forte S than ampicillin-cloxacillin treatment.
Zoetis vet Jude Roberts said these findings underpin the treatment's relaunch and its suitability as a first choice therapy for new clinical mastitis cases.
Lincocin Forte S is a water-based formulation, which Jude says helps achieve good distribution in the udder and can be easier to infuse that oil-based tubes, particularly into hardened quarters associated with E coli infections.
Dr Bradley adds that water-based formulation is likely to be less irritant to udder tissues than oil-based tubes, and may improve distribution. He also suggests that "not being a fluoroquinolone or 3rd/4th generation cephalosporin may also help vets fulfil their 'appropriate and justified' prescribing responsibilities."
The recommended treatment is one 10ml syringe per infected quarter at each of three consecutive milkings. Milk from treated cows can be sold for human consumption 84-hours after the last treatment.References: